Cases & Deals

  • Home
  • Practices
  • West Pharmaceutical Services sells manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

Share

West Pharmaceutical Services sells manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

January 2026

Client(s) West Pharmaceutical Services, Inc.

Jones Day is advising West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, in the sale of all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for $112.5 million at close, subject to working capital and other adjustments.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.